Chief of the Division of Vascular & Endovascular Surgery at New York Presbyterian-Weill Cornell Medicine
New York, NY
Joined September 2015
- Tweets8
- Following46
- Followers255
- Likes5
Brian DeRubertis, MD, FACS retweeted
The first patient has been successfully treated with our Esprit BTK Everolimus Eluting Resorbable Scaffold System, pioneering a new standard of care in BTK treatment.
Thanks @PK_MountSinai and team for your commitment to your patients.
Safety Info: bit.ly/3WAocNk
Brian DeRubertis, MD, FACS retweeted
We followed a great morning with a wonderful afternoon watching the first Esprit BTK commercial case at Columbia performed by @sahilparikhmd @AbbottCardio #ProudtobeAbbott
Brian DeRubertis, MD, FACS retweeted
Spending the morning with @derubertisMD observing the first commercial Esprit BTK case at Cornell is a great way to start the day. We are excited about what this therapy is bringing to patients. @AbbottCardio #ProudtobeAbbott
Brian DeRubertis, MD, FACS retweeted
Abbott Begins LIFE-BTK Trial to Evaluate Esprit BTK Drug-Eluting Resorbable Scaffold to Treat CLI | @AbbottNews
evtoday.com/news/abbott-begi…
Important time for patients suffering the threat of limb loss. Looking forward to the exciting work we have ahead of us in helping to evaluate this technology for our patients. @RamonVarcoeMD @sahilparikhmd
Breaking at #VEITH2019: Announcing the LIFE-BTK pivotal IDE clinical trial to evaluate the safety & effectiveness of ESPRIT BTK, a new everolimus eluting bioresorbable scaffold intended for treating critical limb ischemia!
Read about the #innovativetech:
linkedin.com/pulse/researchi…
